Why?

Richard Branson’s Next Frontier Is Human Genetics as His SPAC Buys 23andMe

Published: Feb. 4, 2021 at 4:18 p.m. ET

Billionaire Richard Branson has invested in everything from commercial space travel to record labels. Now he is getting into the human genome business.

https://www.marketwatch.com/articles/richard-bransons-spac-to-merge-with-gene-testing-firm-23andme-51612473479?mod=mw_latestnews